Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | MEDICINES DISCOVERY CATAPULT LIMITED |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics, on the basis that no reasonable alternative or substitute exists which meets the specific technical and operational requirements of the organisation. Independent comparative studies have demonstrated that alternative platforms currently on the market exhibit significantly higher levels of background noise, reducing data quality in single cell spatial analysis. MDC has verified these performance results and determined that the Xenium system is uniquely capable of delivering the sensitivity and precision required for our research and service activities. Beyond this the Xenium platform also offers operational advantages. It enables the use of panels with a low minimum run size, which aligns closely with the typical experimental scale within MDC. Competing systems require substantially higher minimum slide numbers, making them unsuitable and leading to inefficient use of resources. In addition, acquiring the Xenium system will strengthen MDC's national role by providing UK drug discovery organisations access to a capability that is not currently available within any UK based CRO. This avoids duplication with existing commercial provider and ensures MDC can offer new and complementary capabilities to the wider life sciences community. |
All 3 notices for this procurement, oldest first.
Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult
Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult
Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £344,000 |
| Award status: | Pending |
..
Published contracts in the last 12 months
40
total contracts
£5.8m
total value
£524,999
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 8 December 2025 |
| Application Deadline: | — |
| Contract Start Date: | — |
| Contract End Date: | 17 December 2026 |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-05f0dd |
| Notice Reference: | 080646-2025 |